DROFYL-400 & DROFYL-M tablets are effective bronchodilators that help patients breathe better by relieving airway constriction, wheezing, and shortness of breath. These tablets contain Doxofylline, a xanthine derivative with fewer side effects than traditional theophylline.
DROFYL-M additionally contains Montelukast, providing dual-action relief by reducing airway inflammation and preventing asthma attacks.
Indications
DROFYL tablets are prescribed for:
Chronic Obstructive Pulmonary Disease (COPD) – Improves lung function and airflow.
Asthma – Reduces bronchospasms and enhances breathing.
Chronic Bronchitis & Emphysema – Eases mucus buildup and airway restriction.
Allergic Airway Disorders – Helps prevent asthma triggered by allergens.
DROFYL tablets ensure smoother breathing for individuals suffering from long-term respiratory conditions.
Product Composition & Benefits
| Product | Function & Benefits |
| DROFYL-400 Tablet | Provides bronchodilation for asthma and COPD relief. |
| DROFYL-M Tablet | Dual-action therapy – Reduces inflammation and prevents airway narrowing. |
Doxofylline offers effective bronchodilation with fewer cardiovascular side effects compared to theophylline.
Dosage & Administration
DROFYL-400 Tablet: Take one tablet twice daily or as directed by a doctor.
DROFYL-M Tablet: Take once daily, preferably in the evening, for improved asthma control overnight.
Take with or without food, as per doctor’s guidance.
Do not exceed the prescribed dose to avoid potential side effects.
Precautions & Warnings
Use with caution in heart disease patients due to its mild cardiovascular effects.
May cause mild nausea or dizziness – Avoid driving if you experience these effects.
Not suitable for patients with severe liver or kidney impairment.
Consult a doctor if pregnant or breastfeeding before use.
Avoid alcohol and smoking to maximize the benefits of the medication.
Regular lung function check-ups are recommended while using bronchodilator therapy.
Why Choose DROFYL?
Fast & Effective Bronchodilation – Relieves airway obstruction and breathlessness.
Doxofylline is Safer than Theophylline – Fewer gastrointestinal and cardiac side effects.
Montelukast in DROFYL-M Enhances Asthma Control – Reduces inflammation and prevents exacerbations.
Long-Lasting Effects with Sustained Release Formulation – Ensures continuous relief.
Clinically Proven for COPD & Asthma Management – Recommended by healthcare professionals.
DROFYL tablets provide a reliable and effective solution for chronic respiratory disorders.
DROFYL-400 & DROFYL-M offer targeted relief for asthma, COPD, and allergic airway disorders. With Doxofylline’s superior bronchodilator effect and Montelukast’s anti-inflammatory properties, these tablets provide long-term respiratory support with minimal side effects. Whether you need immediate relief from breathing difficulties or long-term asthma prevention, DROFYL is the ideal choice for respiratory care.
Choose DROFYL for optimal lung health and easy breathing!
Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.
For more such product information and similar product category Anti-Allergic/Anti-Cold & Cough/Steroids
You can also contact us www.allengeindia.com/contact-us
